NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q1 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,536,000 | -30.6% | 89,953 | -0.3% | 0.01% | -33.3% |
| Q3 2016 | $9,415,000 | +42.4% | 90,194 | +0.6% | 0.01% | +50.0% |
| Q2 2016 | $6,612,000 | +105.5% | 89,639 | +56.7% | 0.01% | +100.0% |
| Q1 2016 | $3,218,000 | -14.9% | 57,199 | +2.1% | 0.00% | -20.0% |
| Q4 2015 | $3,781,000 | +45.6% | 56,000 | +0.0% | 0.01% | +25.0% |
| Q3 2015 | $2,597,000 | -5.9% | 55,978 | +9.0% | 0.00% | +33.3% |
| Q2 2015 | $2,760,000 | +139.8% | 51,356 | +113.8% | 0.00% | +50.0% |
| Q1 2015 | $1,151,000 | -22.1% | 24,022 | -37.1% | 0.00% | 0.0% |
| Q4 2014 | $1,477,000 | – | 38,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |